![](/img/cover-not-exists.png)
Continued Afatinib (A) With the Addition of Cetuximab (C) After Progression on Afatinib in Patients With Acquired Resistance (AR) to Gefitinib (G) or Erlotinib (E)
Horn, L., Gettinger, S., Camidge, R., Smit, E., Janjigian, Y., Pao, W., Schnell, D., Wang, B., Chand, V., Groen, H.Volume:
90
Language:
english
Journal:
International Journal of Radiation Oncology*Biology*Physics
DOI:
10.1016/j.ijrobp.2014.08.220
Date:
November, 2014
File:
PDF, 76 KB
english, 2014